Screener
Zevra Therapeutics, Inc. ZVRA Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts payable and accrued expenses | $13,962 | $11,598 |
| Current portion of operating lease liabilities | 626 | 419 |
| Current portion of discount and rebate liabilities | 11,777 | 12,188 |
| Current portion of income tax payable | 20,844 | 13,710 |
| Other current liabilities | 1,423 | 1,362 |
| Total current liabilities | 48,632 | 39,277 |
| Long-term debt | — | 61,928 |
| Warrant liability | 13,165 | 9,575 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s income taxes payable?
- Zevra Therapeutics, Inc. (ZVRA) reported income taxes payable of $20.84M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s income taxes payable changed year-over-year?
- Zevra Therapeutics, Inc.'s income taxes payable increased by 19.3% year-over-year, from $17.48M to $20.84M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about Zevra Therapeutics, Inc.'s income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude